Researchers excluded participants who had other chronic liver problems besides nonalcoholic fatty liver disease ... treatment modalities. The study in the NEJM showing possible benefits of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Experts say semaglutide may be a much-needed treatment option for a liver disease with few current therapies. Ozempic is effective in treating a severe form of liver disease that affects millions ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...